Lecture 10 - Benzos Flashcards

1
Q

List some GABAergic Sedative-Hypnotic Drugs

A
  • Chloral Hydrate
  • Meprobamate
  • Barbiturates
  • Benzodiazepines
  • Z-Drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

BZD overdose in ____ is almost never fatal

A

isolation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Why are barbiturates more toxic than BZD?

A

have a more narrow therapeutic window

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are patient factors that predispose them to BZD overdose?

A
  • age
  • hepatic impairment
  • COPD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

describe sedative-hypnotic symptoms

A
  • sedation, disinhibition, anxiolysis
  • hypnosis
  • anesthesia
  • medullary depression
  • coma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe the mild CNS symptoms

A

drowsiness or lethargy may appear within 30-60 mins of ingestion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe the moderate CNS symptoms

A

slurred speech, amnesia, ataxia, may appear shortly after the mild symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe the severe CNS symptoms

A

stupor or coma may occur hours after large ingestions alone of sooner if polydrug overdose

*usually accompanied by: hypothermia, hyporeflexia, miosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe the rare CNS symptoms

A

agitation, aggression with confusion may occur (more common in elderly)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What has the most respiratory symptoms in toxicity: barbiturates, benzos, or z drugs?

A

barbiturates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

T or F: CNS depression always predicts respiratory depression

A

False: does not always predict it

i.e. patient in stupor or coma may have normal vital signs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are risks for respiratory symptoms during toxicity?

A
  • respiratory disease
  • elderly
  • concomitant opioid use
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What RR defines hypoventilation?

A

RR < 12 breaths/minute for adults

*if patient is apneic (breathing is suspended) or cyanotic (skin is blue), death may be imminent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Which drugs are CV side effects seen in toxicity: barbiturates, BZD, or Z drugs?

A

barbiturates!

*negligible CVD effects from BZD and Z-Drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are CV effects that are produced with toxicity (specifically with barbiturates) ?

A
  • postural hypotension
  • bradycardia

*specifically in those at risk patients (elderly with pre-existing CVD)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Cardiovascular collapse is rare, but may occur with large combined _____ or _____ overdose.

A

alcohol or opioid

17
Q

Bullous fixed drug eruptions may occur with ______ and rarely with BZD
*idiosyncratic drug effect

A

barbiturates

18
Q

________ is common in severe overdose and may be accompanied by ____ as the poisoning progresses

A
  • hypothermia

- cyanosis

19
Q

Which benzo’s have some studies saying that they are more toxic?

A
  • alprazolam
  • flurazepam
  • temazepam
20
Q

Why do Z drugs possibly have less risk?

A

once daily dosing

i.e. lesser dispensing quantities compared to BZD

21
Q

which gender has more deaths from BZD?

22
Q

What is the unholy trinity?

A
  • BZD
  • Opioids
  • Skeletal Muscle Relaxants

*can get additive euphoric symptoms

23
Q

Describe the management of the intoxicated patient

A

Emergency and supportive measures:

  • protect airways, assist ventilation
  • treat coma
  • treat hypotension
  • treat hypothermia

Decontamination:

  • activated charcoal for poly-drug overdose (limited utility in mono-drug overdose - aspiration risk)
  • Urinary alkinization for barbiturates (esp. phenobarbital)
  • Antidotes: Flumazenil ? - it is controversial (it is a BZD receptor antagonist)
24
Q

What is Flumazenil ?

A

-competitive antagonist of BZ receptor

25
What can Flumazenil reverse?
BZD and Z-drug induced CNS depression
26
What can Flumazenil induce?
BZD withdrawal
27
In what situation is Flumazenil ideal?
for BZ-naive patients with BZ only overdose
28
What is the dose of Flumazenil?
0. 1-0.2 mg IV over 30 seconds | - subsequent doses of 0.3mg and 0.5mg at 1 min interval up to 3mg total
29
_______ is common after 1-2 hours of flumazenil ?
re-sedation *common with naloxone as well
30
When should we avoid using Flumazenil?
- Patient is physically dependent (withdrawal situation) - Patient is receiving BZ for control of seizure - Pre-existing cardiac arrhythmia or high-risk of arrhythmia - Coingestion of agents causing seizures (theophylline, TCAs, etc.) - Increased intracranial pressure - Unreliable/unavailable history
31
Describe the characteristics of the patient in an ideal scenario for Flumazenil
PURE benzodiazepine overdose in a nontolerant (BZD-naive) individual who has: - CNS depression - normal vital signs, including Saturated O2 - normal ECG - otherwise normal neurologic examination
32
Has long-term use of BZD been associated with cumulative toxicity or organ damage?
nope
33
What are some common clinical consequences of chronic use of BZD?
Tolerance and dependence during continuous use and withdrawal after cessation of drug
34
What are some strong predictors of long term BZD use?
- female gender - older age *role for pharmacist education and risk reduction (i.e. falls and fractures)
35
What are some BZD/Z-drug use emerging issues that have yet to be unproven?
- infections - pancreatitis - dementia - cancer
36
What are some pharmacotherapy substitutions for BZD?
- longer-acting BZD - pregabalin - carbamazepine - melatonin - flumazenil (patch?)
37
How can we treat BZD dependency?
- pharmacotherapy substitutions | - gradual dose reduction +/- behavioural or psychological interventions
38
Describe a gradual dose reduction of BZD?
-decrease dose by 10-25% q1-2 weeks - slower taper may be needed for final 20%
39
What is absolutely essential for successful discontinuation?
patient "buy-in"